Login
Toggle navigation
Videos
Categories
Trending
Hemcheck | CEO interview, Joen Averstad, CEO, Hemcheck
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Hemcheck | CEO interview, Joen Averstad, CEO, Hemcheck
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Johanna Barr of Advent International Shares Insights on Private Equity Trends and Opportunities at IPM Conference|Johanna Barr - Managing Director, Advent International
00:10:00
Navigating the CBD Market: Insights from Voyager’s CEO | Nick Tulloch, CEO, Voyager Life PLC.
00:10:00
Investment Overview: Fixed Income, Election Insights, and Stock Growth - David and Ben | Hilltop Wealth Advisors
00:10:00
Exploring Teen Views on Money and Life with Sylvie: Insights from a High Schooler
00:10:00
Shilpa Kumar, MD & CEO of ICICI Securities, discusses the impact of the TER decrease on the mutual funds industry.
00:10:00
Standard Chartered's Strategic Outlook: Growth, Resilience, and Market Dynamics | Bill Winters, CEO, Standard Chartered.
00:10:00
Decentralized Energy Generation: Immediate Solutions for Sustainable Development and Economic Prosperity | Louis Maurice, CEO, Groupe Okwind SA.
00:10:00
Monica Pedroza: Inspired Pro Bono Work at Morgan Lewis | MONICA C. PEDROZA - ASSOCIATE of Morgan, Lewis & Bockius LLP
00:10:00
Evolution and Triumphs in the Nordic Tech Arena: A Decade of Innovation and Global Impact | Tellef Thorleifsson, CEO, Norfund.
00:10:00
Addressing the Trillion-Pound Investment Needed for Environmental Impact | Susan Davy, CEO , Pennon Group PLC.
00:10:00
Angie Hicks on Home Maintenance and DIY During the Pandemic | Angie Hicks, Co-Founder, Angi Inc.
00:10:00
Exploring Market Volatility and Distressed Investing with Ed Testerman of King Street Capital